Heart drug trial aims to strengthen weakened aorta
NCT ID NCT07483177
Summary
This small pilot study is testing if a common blood pressure medication called spironolactone can reduce stiffness in the main artery leaving the heart (the aorta) in people with a thoracic aortic aneurysm. The goal is to see if the drug helps control the condition by making the artery wall more flexible. Researchers will compare the drug's effects against a placebo in 50 adults who have this type of aneurysm but do not have certain genetic conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THORACIC AORTIC ANEURYSM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.